Mariya Moosajee, MBBS, BSc, PhD, FRCOphth

August 25, 2021

Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.

August 23, 2021

The impact of the COVID-19 pandemic on the management of patients with retinal disorders and considerations for how new practices may be adopted into future practice.

August 18, 2021

Dr Mariya Moosajee comments on the next generation of gene therapy for inherited retinal disease and highlights various systems under investigation.

August 16, 2021

Considerations for treating retinal disorders with sustained-release drug delivery implants in an effort to address current treatment challenges in the field.

August 11, 2021

An overview of delivery systems under investigation for retinal disorders and implications for future use.

August 09, 2021

A discussion highlighting new agents under investigation for retinal disorders and implications for future use based on data revealed in more recent clinical trials.

August 04, 2021

Ophthalmologists highlight recent treatment advances in diabetic macular edema and wet age-related macular degeneration.

August 02, 2021

Types of delivery methods currently being explored to improve treatment for patients with retinal disorders.

July 26, 2021

Following a discussion regarding drug delivery challenges in retinal disease, a panel of global experts suggest what types of technological requirements and improvements they would like to see occur in the field.

July 26, 2021

Challenges associated with delivering therapies currently available to treat retinal disorders and methods being explored to improve drug delivery to patients.